The two angry billionaires fought the deal in their own ways. Icahn deployed his preferred plan of attack, the proxy battle. Deason pledged to back Icahn's slate of four new directors, but also went his own way by fighting in the courts. He brought two sweeping lawsuits through his attorneys at King & Spalding, unveiled in February and March. The first claimed that because Xerox had concealed a poison pill provision, the company was obligated to grant Deason's demand to extend the nominating deadline so that he could replace the entire board. The second, brought against both Xerox and Fuji, charged that Xerox's board and CEO blatantly violated their fiduciary duties by negotiating a deal that promoted their own interests, while sticking Xerox shareholders with a bad deal, and accused Fuji of conspiring in a quid pro quo--the CEO delivers a bargain price, and Fuji puts him in charge of the new Fuji Xerox.